Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: January Research Highlights
Released: 31-Jan-2023 12:00 PM EST
January Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Released: 31-Jan-2023 10:00 AM EST
Findings of large clinical trial has major implications for the treatment of small-cell lung cancer.
SUNY Upstate Medical University

The largest trial in limited-stage small cell lung cancer ever suggests similar outcomes and long-term survival in patients treated with twice-a-day versus once-a-day radiotherapy.

Newswise: Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Released: 27-Jan-2023 9:20 AM EST
Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains
Johns Hopkins Medicine

Johns Hopkins Medicine investigators say their research indicates a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant (MDR) strains

Released: 25-Jan-2023 6:05 AM EST
UCLA Health Tip Sheet January 25, 2023
University of California, Los Angeles (UCLA), Health Sciences

Below is a brief roundup of news and story ideas from the experts at UCLA Health.

Released: 24-Jan-2023 5:25 PM EST
New Recommendations Aim to Help Prevent Future Lung Injuries from Vaping
University of Maryland School of Medicine

Nearly four years ago, federal health officials reported on a frightening new epidemic linked to e-cigarette use that caused a life-threatening and potentially irreversible lung condition.

Released: 24-Jan-2023 2:40 PM EST
Save children from common cold with higher physical activity
Springer

Higher physical activity levels associated with reduced respiratory infection such as the common cold susceptibility in children.

Newswise: Stories With Heart: Tipsheet From Smidt Heart Institute at Cedars-Sinai
Released: 24-Jan-2023 1:30 PM EST
Stories With Heart: Tipsheet From Smidt Heart Institute at Cedars-Sinai
Cedars-Sinai

Cardiologists and surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews during Heart Month on an array of cardio-related topics.

Released: 23-Jan-2023 2:05 PM EST
Thomas E. MacGillivray, MD, Elected President of The Society of Thoracic Surgeons
The Society of Thoracic Surgeons

Cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, was elected President of The Society of Thoracic Surgeons at STS 2023 during the Society’s Business Meeting.

Released: 21-Jan-2023 6:05 PM EST
STS Annual Meeting Session Rallies Proven Methods to Combat Racial, Gender Disparities in Heart and Lung Disease
The Society of Thoracic Surgeons

Identifying and closing gaps and disparities in health care subject of scientific session at the 59th Annual Meeting of The Society of Thoracic Surgeons.

Released: 20-Jan-2023 7:45 PM EST
Investigators capture a “molecular snapshot” to illuminate the origins of pulmonary arterial hypertension
Brigham and Women’s Hospital

Pulmonary arterial hypertension (PAH) is a rare and incurable disease of the lung arteries that causes early death.

Newswise: ‘Living medicine’ created to tackle drug-resistant lung infections
Released: 19-Jan-2023 6:40 PM EST
‘Living medicine’ created to tackle drug-resistant lung infections
Center for Genomic Regulation

Researchers have designed the first ‘living medicine’ to treat lung infections.

Newswise: MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
Released: 19-Jan-2023 11:00 AM EST
MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a new state-of-the-art Biocontainment Unit (BCU) to care for patients who contract highly infectious diseases. Located near the Emergency Room, the new multi-purpose 15-bed unit will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly contagious conditions, such as Ebola.

Released: 19-Jan-2023 10:05 AM EST
Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation
The Society of Thoracic Surgeons

In an article published jointly on January 18, 2023, in both The Annals of Thoracic Surgery and the Journal of the American College of Cardiology, leading cardiology and cardiothoracic surgical researchers analyzed recent national data to assess the outcomes and risk of mitral valve repair for primary mitral regurgitation.

Released: 19-Jan-2023 9:00 AM EST
MD Anderson EGFR Classification licensed by BostonGene and Tempus to provide new insight on atypical mutations in lung cancer
University of Texas MD Anderson Cancer Center

MD Anderson announced licensing agreements with BostonGene and Tempus for the MD Anderson EGFR Classification, which organizes EGFR mutations into subgroups that may guide clinical decision-making.

Newswise: Quality of treatment for lung cancer varies widely across US
17-Jan-2023 3:40 PM EST
Quality of treatment for lung cancer varies widely across US
Washington University in St. Louis

A new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely. The findings show that high-quality care is associated with improved overall survival rates among patients with lung cancer.

Released: 17-Jan-2023 2:50 PM EST
Frequent visits to green space linked to lower use of certain prescription meds
BMJ

Frequent visits to urban green spaces, such as parks and community gardens in Finland, rather than the amount, or views of them from home, may be linked to lower use of certain prescription meds, suggests research published online in Occupational & Environmental Medicine.

Released: 17-Jan-2023 1:40 PM EST
UC Irvine, UCLA researchers identify new therapeutic approach to prevent ARDS
University of California, Irvine

A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS. Their study, which appears in iScience, describes the first specific treatment designed to prevent the deadly disease, which can appear in patients with severe lung injury from infections with bacteria and viruses, like pneumonia, flu, respiratory syncytial virus (RSV) and COVID-19.

Released: 17-Jan-2023 12:45 PM EST
Mucosal antibodies in the airways provide durable protection against SARS-CoV-2
Karolinska Institute

High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection.

Newswise: Preparing for Coming RSV, Influenza Epidemics
12-Jan-2023 12:00 PM EST
Preparing for Coming RSV, Influenza Epidemics
American Institute of Physics (AIP)

Nonpharmaceutical interventions slowed the spread of COVID-19 and other infectious diseases but now, as NPIs are lifted, countries are seeing a resurgence in several respiratory diseases. In Chaos, scientists, using data from Hong Kong to develop their model, describe a threshold control method that can be used to predict the best time to lift NPIs without overwhelming the hospital systems when these other respiratory diseases inevitably surge back. They found that reintroducing NPI measures when a threshold of 600 severe cases is reached could ensure that the hospital system in Hong Kong is not overwhelmed by severely infected patients.

   


close
2.46387